A large clinical trial evaluating Atea Pharmaceuticals’ fixed-dose oral combination of bemnifosbuvir and ruzasvir in adults with chronic hepatitis C remains on track,…
News
CHOLANGITIS
NewsItching drives healthcare costs higher for PBC patients, study finds
People with primary biliary cholangitis (PBC) who experience itching (pruritus) use more healthcare resources and have significantly higher medical costs than those without this…
A new prediction tool may help assess the risk of preterm birth (before 37 weeks of gestation) in women affected by intrahepatic cholestasis of…
FATTY LIVER DISEASE
NewsBelapectin shows signs of benefit in MASH Phase 2b clinical trial
Belapectin, Galectin Therapeutics’ investigational therapy, significantly reduced the development of new enlarged blood vessels in the esophagus among people with metabolic dysfunction-associated steatohepatitis (MASH),…
ALAGILLE SYNDROME
NewsItching at night tied to sleep problems for Alagille kids – and their caregivers
Due to itching at nighttime, children with Alagille syndrome often experience substantial problems getting a good night’s sleep, leading to poor rest not only…
GlaxoSmithKline (GSK) has submitted an application to Health Canada seeking approval of its chronic hepatitis B therapy bepirovirsen for treating adults with the…
Low blood levels of vitamin B6 — found in certain foods and essential for metabolism and immune function in the body — can increase the…
Rare genetic liver conditions like progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome pose a substantial financial and quality-of-life burden on families, a study…
FATTY LIVER DISEASE
NewsMadrigal Pharmaceuticals expands MASH pipeline with genetic treatment
Madrigal Pharmaceuticals has secured worldwide rights to develop ARO-PNPLA3, an experimental treatment created by Arrowhead Pharmaceuticals for people with metabolic dysfunction-associated steatohepatitis (MASH),…
BILIARY ATRESIA
NewsCMV marker in bile duct cells tied to worse biliary atresia outcomes
Children with biliary atresia who had evidence of active cytomegalovirus (CMV) infection involving bile duct cells in the liver had signs of more severe…
Recent Posts
- Top-line Phase 2 trial data for hepatitis C combo therapy expected soon
- Itching drives healthcare costs higher for PBC patients, study finds
- Mystery symptoms and MASH: Your doctor is an ally in solving the puzzle
- Prediction tool helps spot preterm birth risk in ICP twin pregnancies
- Seeing that my son was tall enough to play was a joyful moment